| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |